Course Overview:
This 50-minute eLearning provides healthcare providers with a practical overview of hepatocellular carcinoma (HCC), which can be caused by chronic viral hepatitis infection. The course explores the HCC care pathway, from understanding risk factors through to patient management, with interactive activities designed to reinforce learning and support best practice in clinical care.
Course learning outcomes:
Upon successful completion of the course, you will be able to:
- Explain the epidemiology and risk factors for HCC, focusing on the role of viral hepatitis
- Outline the surveillance process for HCC
- Discuss diagnosis and staging of HCC
- Compare HCC treatment options
- Recognise your role in managing viral hepatitis patients with HCC
CPD:
- 1 HBV Prescriber Point for accredited Hepatitis B s100 Prescribers.
- ACRRM: This course has been approved by ACRRM as an accredited activity. Allocated total 1 PDP units: 0.75 Educational Activity and 0.25 Performance Review.
- RACGP: This course has been approved as a CPD activity by RACGP for the 2023-2025 triennium. Educational Activities: 1 hour.
- APNA: This activity has been endorsed by APNA according to approved quality standards criteria. Completion of these educational activities entitles eligible participants to claim 50 CPD minutes.
Contact: Please email [email protected] if you require assistance or have a clinical question you would like to raise with a medical educator.
Important: Please use the latest version of Google Chrome browser and enable popups/active content while completing this course.
Last updated: August 2025
Acknowledgements: Thank you to Elisabeth Stratton and Alice Lee for their valuable contributions to the development and review of this activity.
Funders: This activity has been developed with funding from the Queensland Government Department of Health.
